Truist Financial
TEVA icon

Truist Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Truist Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3M Sell
392,480
-33,760
-8% -$1.12M 0.02% 558
2026
Q1 		$12.8M Sell
426,240
-249,930
-37% -$8.04M 0.02% 535
2025
Q4 		$21.1M Sell
676,170
-296,745
-31% -$7.31M 0.03% 398
2025
Q3 		$19.7M Sell
972,915
-38,775
-4% -$681K 0.03% 417
2025
Q2 		$17M Sell
1,011,690
-261,940
-21% -$4.23M 0.02% 443
2025
Q1 		$19.6M Sell
1,273,630
-98,794
-7% -$1.76M 0.03% 395
2024
Q4 		$30.2M Sell
1,372,424
-16,398
-1% -$298K 0.05% 308
2024
Q3 		$25M Sell
1,388,822
-2,496,429
-64% -$43.7M 0.04% 342
2024
Q2 		$63.1M Buy
3,885,251
+254,483
+7% +$3.92M 0.1% 197
2024
Q1 		$51.2M Buy
3,630,768
+3,496,746
+2,609% +$44.1M 0.08% 234
2023
Q4 		$1.4M Buy
134,022
+1,766
+1% +$16.5K ﹤0.01% 1442
2023
Q3 		$1.35M Sell
132,256
-41,895
-24% -$390K ﹤0.01% 1431
2023
Q2 		$1.31M Buy
174,151
+36,712
+27% +$298K ﹤0.01% 1446
2023
Q1 		$1.22M Sell
137,439
-13,697
-9% -$135K ﹤0.01% 1463
2022
Q4 		$1.38M Sell
151,136
-8,225
-5% -$71.8K ﹤0.01% 1400
2022
Q3 		$1.29M Buy
159,361
+25,472
+19% +$225K ﹤0.01% 1385
2022
Q2 		$1.01M Sell
133,889
-30,152
-18% -$263K ﹤0.01% 1544
2022
Q1 		$1.54M Sell
164,041
-6,821
-4% -$56.9K ﹤0.01% 1411
2021
Q4 		$1.37M Buy
170,862
+35,005
+26% +$316K ﹤0.01% 1477
2021
Q3 		$1.32M Buy
135,857
+23,566
+21% +$221K ﹤0.01% 1459
2021
Q2 		$1.11M Sell
112,291
-2,223
-2% -$23.5K ﹤0.01% 1577
2021
Q1 		$1.32M Buy
114,514
+72,768
+174% +$834K ﹤0.01% 1427
2020
Q4 		$402K Sell
41,746
-68,665
-62% -$658K ﹤0.01% 1978
2020
Q3 		$995K Buy
110,411
+1,120
+1% +$11.8K ﹤0.01% 1373
2020
Q2 		$1.35M Sell
109,291
-14,417
-12% -$163K ﹤0.01% 1174
2020
Q1 		$1.11M Sell
123,708
-4,913
-4% -$50.3K ﹤0.01% 1223
2019
Q4 		$1.26M Buy
+128,621
New +$1.15M ﹤0.01% 1343
2016
Q4 		– Sell
-5,804
Closed -$267K – 860
2016
Q3 		$267K Sell
5,804
-7,706
-57% -$402K 0.01% 720
2016
Q2 		$679K Sell
13,510
-9,487
-41% -$505K 0.01% 541
2016
Q1 		$1.23M Sell
22,997
-2,130
-8% -$125K 0.03% 400
2015
Q4 		$1.65M Sell
25,127
-2,070
-8% -$128K 0.04% 343
2015
Q3 		$1.54M Sell
27,197
-4,141
-13% -$268K 0.04% 352
2015
Q2 		$1.85M Sell
31,338
-4,705
-13% -$290K 0.05% 302
2015
Q1 		$2.25M Buy
36,043
+1,954
+6% +$114K 0.06% 270
2014
Q4 		$1.96M Buy
34,089
+3,033
+10% +$169K 0.06% 289
2014
Q3 		$1.67M Sell
31,056
-1,913
-6% -$101K 0.05% 294
2014
Q2 		$1.73M Sell
32,969
-41,483
-56% -$2.12M 0.05% 299
2014
Q1 		$3.93M Sell
74,452
-59,932
-45% -$2.77M 0.12% 203
2013
Q4 		$5.39M Buy
134,384
+3,071
+2% +$121K 0.17% 146
2013
Q3 		$4.96M Sell
131,313
-938
-0.7% -$36.6K 0.18% 148
2013
Q2 		$5.18M Buy
+132,251
New +$5.15M 0.19% 140

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Truist Financial's TEVA Position: Q2 2026 in Review

Truist Financial reduced its Teva Pharmaceuticals (TEVA) stake by 7.9% in Q2 2026, selling an estimated $1.12M and leaving 392,480 shares worth $13.3M. The position accounts for 0.02% of the portfolio, ranked #558.

Truist Financial first reported a position in TEVA in Q2 2013 and has held it in 41 quarters since. The position peaked at $63.1M in Q2 2024. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Truist Financial held 392,480 shares of Teva Pharmaceuticals worth $13.3M as of Q2 2026.
  • Truist Financial sold 33,760 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.12M.
  • Teva Pharmaceuticals made up 0.02% of Truist Financial's portfolio in Q2 2026, its #558 holding.
  • Truist Financial first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 41 quarters since.
  • Truist Financial's Teva Pharmaceuticals position peaked at $63.1M in Q2 2024.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.